riday April 17, 3:23 pm Eastern Time
Company Press Release
SOURCE: Chromatics Color Sciences International, Inc.
Chromatics Color Sciences Names Hill and Knowlton Public Relations Counsel as Company Moves Toward Next Phase in its Development
NEW YORK, April 17 /PRNewswire/ -- Chromatics Color Sciences International, Inc. (NASDAQ: CCSI - news) announced today that it has retained Hill and Knowlton, Inc. to direct the Company's corporate public relations, investor relations and financial communications efforts.
''We are extremely pleased that Hill and Knowlton is joining with Chromatics as we move into an accelerated phase of our corporate development,'' said Darby S. Macfarlane, chairperson of the board and chief executive officer.
''In line with our firm commitment to growth and enhancing shareholder value, we believe that this is the appropriate time to seek wider support within the investment community. We believe that Hill and Knowlton, a premier public relations firm distinguished by its experience and accomplishments in working with a diverse client base, will provide significant assistance in communicating our exciting story to the investment community and other important audiences.''
The Company is engaged in the business of color science and has developed technologies and intellectual properties which the Company believes have medical applications involving the detection and monitoring of certain chromogenic diseases or disorders such as bilirubin infant jaundice. In this regard, the
Company has received FDA clearance for commercial marketing of the Company's medical device for detection and monitoring of bilirubin infant jaundice.
Other medical applications will most likely require additional clinical trials and FDA clearance. The Company defines chromogenic disease or disorders as those diagnosed or monitored by the coloration of the human skin, tissue or fluid being affected. These technologies and intellectual properties also have other applications including the scientific color measurement and classification of human skin, certain color-sensitive consumer products, and in determining
the color compatibility of such skin and product color classification for use in a variety of industries including the cosmetic, beauty aid and fashion industries. The Company's common stock is traded on Nasdaq under the symbol ''CCSI''.
Certain of the matters discussed in this announcement contain forward- looking statements that involve material risks to and uncertainties in the Company's business which may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, the availability of any needed financing, the Company's ability to implement its long range business plan for various applications for its
technologies, the impact of competition, the obtaining of further regulatory clearances applicable to proposed new applications of the Company's technology, management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, including those set forth in its annual report on Form 10-K for the year ended December 31, 1997.
SOURCE: Chromatics Color Sciences International, Inc. |
